Low copper-2 intake in Switzerland does not result in lower incidence of Alzheimer's disease and contradicts the Copper-2 Hypothesis.

MLA

Solioz, Marc. “Low Copper-2 Intake in Switzerland Does Not Result in Lower Incidence of Alzheimer’s Disease and Contradicts the Copper-2 Hypothesis.” Experimental Biology and Medicine (Maywood, N.J.), vol. 245, no. 3, Feb. 2020, pp. 177–79. EBSCOhost, https://doi.org/10.1177/1535370219899898.

APA

Solioz, M. (2020). Low copper-2 intake in Switzerland does not result in lower incidence of Alzheimer’s disease and contradicts the Copper-2 Hypothesis. Experimental Biology and Medicine (Maywood, N.J.), 245(3), 177–179. https://doi.org/10.1177/1535370219899898

Chicago

Solioz, Marc. 2020. “Low Copper-2 Intake in Switzerland Does Not Result in Lower Incidence of Alzheimer’s Disease and Contradicts the Copper-2 Hypothesis.” Experimental Biology and Medicine (Maywood, N.J.) 245 (3): 177–79. doi:10.1177/1535370219899898.